Curriculum Vitae State University of New York at Stony Brook Health Sciences Center Name: Patricia K. Coyle Birthplace: New York City Mailing Address: HSC T12, Room 20 Stony Brook, NY 11794-8121 Home Telephone: (631) 473-8932 Work Telephone: (631) 444-8188 Higher Education (Including Internship, Residency & other formal professional training) From To Degree and Date Institution, Location & Field 9/1966 6/1970 B.S. 1970 Fordham University, NY Honors Program, Summa Cum Laude in Cursu Honorum 7/1970 6/1974 M.D. 1974 Johns Hopkins, MD Medicine, AOA 7/1974 6/1975 Internship Cornell, NY Hospital Medicine 7/1975 6/1977 Residency Johns Hopkins, MD Neurology 7/1977 6/1978 Chief Resident Johns Hopkins, MD Neurology 7/1978 6/1980 Research Fellow Johns Hopkins, MD Neuroimmunology and Neurovirology 1 Certification & Licensure (ECFMG, FLEX, National & Professional Boards & Licenses) Date Agency January 1980 American Board of Psychiatry & Neurology (ABPN) 2004 Recertification, ABPN July 1980 New York State Medical License #124559 Appointments (Academic Appointments) Date Title Status* Institution & Location 7/80 – 6/88 Ass’t. Prof. S SUNY – Stony Brook 7/88 – 3/93 Assoc. Prof. T SUNY – Stony Brook 3/93 – present Professor T SUNY – Stony Brook 10/88 – 4/89 Acting Chair SUNY – Stony Brook 10/91 – 6/92 Acting Chair SUNY – Stony Brook 3/03 – 9/12 Acting Chair SUNY – Stony Brook 10/12 – present Vice Chair SUNY – Stony Brook (Clinical Affairs) *Status: Voluntary (V), Salaried (S), Tenured (T) Other Appointments Date Title Status Institution & Location 7/80 – present Attending Neurologist S University Medical Center, Stony Brook 7/80 – 1995 Attending Neurologist V Northport VAMC 8/87 – 1993 Consultant V Central Islip Psychiatric Center 2 Professional Practice & Services Date Activity Location Institution Affiliation(s) 7/1980 – present Attending Neurologist Stony Brook SUNY – Stony Brook Univ. Hospital 7/1980 – 1995 Staff Neurologist Northport VAMC SUNY – Stony Brook Professional & Scientific Societies Date Organization 2015 - Member, Scientific Advisory Panel, Southampton Hospital Resource Center 1977 – present American Academy of Neurology (AAN) 1990 – 1994 Chair, Infectious Disease Task Force, Self-Assessment Steering Committee 1980 – 2005 American Association for the Advancement of Science 1980 – 1990 American Federation for Clinical Research 1980 – 2005 American Society of Microbiology 1982 – 1986 Medical and Scientific Advisory Board, ARDA (Nassau/Suffolk County Chapter) 1980 – 2000 New York Academy of Science 1987 – 1991 Medical Board, National Multiple Sclerosis (MS) Society 1992 – present 1988 – 2004 Clinical Advisory Committee (CAC) 1988 – 2001 Long Island MS Society Chair (CAC) 1988 – 1994 Association for Research in Vision and Ophthalmology 1989 – 1992 Society for Experimental Neuropathology 1992 – 1994 Association of Medical Laboratory Immunologists 1991 – 2003 AAN Graduate Education Subcommittee (GES) 1997 – 2003 Chair, GES 1992 – 1997 AAN Annual Meeting Subcommittee 3 1993 – 1997 AAN Scientific Issues Committee 1994 – 1997 AAN Public and Professional Information Committee (Liaison member) 1997 – 2003 AAN Education Committee 1999 AAN Reviewer, Infectious Disease Abstracts 1992 – present Elected Member, American Neurological Association (ANA) 1998 – 1999 Member, ANA Education Committee 1996 – 1997 Member, ANA Nominating Committee 2001 – 2003 Councilor, ANA; member, ANA Scientific Program Committee 1995 – 1998 Infectious Disease Society of America 1997 – 1999 National MS Society 2000 – 2002 Professional Education Committee 1997 – 2003 National MS Society Advisory Committee for the Compendium of MS Information 1999 – 2003 NARCOMS, Management Team, MS Registry 1997 – present Member, AAN MS section 2000 – 2002 Chair, MS section 2000 – 2001 Member, Scientific Committee, Cost modeling in MS 2001 – 2008 Member, Advisory Board, NARCOMS Project, Consortium of MS Centers (CMSC) 2001 – 2008 Member, Board of Directors, American Academy of Immunotherapy 2001 – 2002 Development-Vice Chair, Consortium of MS Centers 2001 – 2012 Editor-in-Chief, Neura 2003 – present Member, NYSMSC Executive Committee 2007 DSMB, Member, Betaseron Pregnancy Registry 2007 Co-Chair, Committee on Maintenance of Certification 2007 Member, Part 1 Neurology C Examination Committee 2008 Chair, DSMB Committee, Forte Trial 4 2008 Steering Committee, REGARD Trial 2008 Steering Committee, ORACLE Trial 2008 Vice President, American Board of Psychiatry & Neurology 2008 Chair, Neurology Council Academic & Professional Honors Date Honor 2018 Activity Chair & Speaker, Vindico Medical Education, “MS Forum V: Applying Clinical Advances and Shared Decision-making to Improve Quality Care,” October 27, November 3 & 17, December 1, 2018. 2018 Chair, Sanofi Genzyme 2018 multiple sclerosis (MS) Satellite Symposium: “Switching MS Treatments: Patient Trajectory, Prior Response and Real World Evidence to Inform Decision Making,” Berlin, Germany, October 12, 2018. 2018 Chair, Sanofi Genzyme Global Women in MS Advisory Board, Zurich, Switzerland, Jun 30, 2018. 2018 Invited Faculty, AUBAGIO & LEMTRADA Academy of Knowledge Meeting, Amsterdam, Netherlands, June 8-9, 2018. 2018 Invited Speaker, Roche 1st Neurology Interchange Meeting, “Breaking Paradigms In Multiple Sclerosis Management” - Ocrevus Brazilian Launch Meeting, Rio de Janeiro, Brazil, May 5, 2018. 2018 Invited Speaker, Sanofi Genzyme AAN 2018 Industry Therapeutic Update, “Predicting Patient Trajectory in MS: How Advanced Prognostic Measures Can Support More Informed Treatment Decisions,” American Academy of Neurology, Los Angeles CA, April 25, 2018. 2018 Faculty, Sanofi Genzyme, MS Global Strategic Advisory Board Meeting, Cambridge, MA, March 12-13, 2018. 2018 Invited Speaker, Neurology Association of South Africa, Durban, South Africa, March 8, 2018. 2018 New York Super Doctors 2018 2017 Invited Speaker, Region Europe Ocrelizumab Launch Meeting, London, England, November 28, 2017. 5 2017 Invited Faculty, 2017 Joint Academy of Knowledge, Berlin, Germany, November 17-18, 2017. 2017 Activity Chair & Speaker, Vindico MS Forum IV, November 4, 11; December 2, 9 2017 Invited Faculty, 2017 Joint Academy of Knowledge- Emerging Markets, Dubai, United Arab Emirates, October 6-7, 2017. 2017 Invited Faculty, Sanofi Genzyme Multiple Sclerosis (MS) Global Strategic Advisory Board Meeting, Cambridge, MA, September 25-26, 2017 2017 Chair, Sanofi Genzyme, Global Women in Multiple Sclerosis (MS): Advisory Board Meeting, Sevilla, Spain, September 16, 2017. 2017 Invited Speaker and Panelist, Teva’s CNS Weekend 2017, “Emerging Treatment Principles in MS in the Personalized Treatment Era,” Australia, July 21-28, 2017. 2017 Invited Faculty and Speaker, AUBAGIO Academy of Knowledge, Barcelona, Spain, June 16-17, 2017. 2017 Invited Speaker, Sanofi Genzyme, “What’s New 2017: Optimizing Treatment Outcomes,” Madrid, Spain, June 3, 2017. 2017 Invited Speaker, Sanofi Genzyme MS Expert Roundtable meeting, “Real World Experience,” “Women and MS: Therapy Issues,” “NNT: The Statistics in Daily Practice,” “MS Center Experience,” Buenos Aires, Argentina, May 31-June 1, 2017. 2017 Chair, CMSC Symposium, “Update on Gender Issues in MS,” New Orleans, LA, May 25, 2017. 2017 Chair, Sanofi Genzyme Advisory Board Meeting, Cartagena, Colombia, May 4, 2017. 2017 Chair, Sanofi Genzyme AAN ITU, “Understanding Functional Improvement in the RMS patient: Is there evidence of neuropreservation and repair?,” Boston MA, April 26, 2017. 2017 Invited Speaker, Biogen MS INnovation, “New Trends in Neuroinflammation and Regeneration Processes in MS,” “Neuroprotective Trends,” Buenos Aires, Argentina, March 16-17, 2017. 2017 Faculty Consultant, The Science of MS Management, “Managing Progressive Multiple Sclerosis: Now What?” Volume 6, Number 3, Winter 2016/2017. 2017 Chair, Aubagio US Speaker training, Dallas, TX, March 4, 2017. 6 2017 Invited Speaker, Global Launch Excellence Meeting (GLEM) 2017, “Real World Evidence (RWE) of AUBAGIO use in multiple sclerosis,” Lisbon, Portugal, February 15, 2017. 2017 Invited Speaker, Aubagio & Lemtrada Academy of Knowledge Joint Meeting, “AUBAGIO Safety, Tolerability and Family Planning,” “Optimizing Treatment Outcomes,” Stockholm, Sweden, February 10-11, 2017. 2017 New York Super Doctors® 2017 2016 Keynote Speaker, Biogen’s PLEGRIDY Launch Event, Santiago, Chile, December 1, 2016. 2016 Advisor, Genzyme Sanofi Multiple Sclerosis (MS) Global Strategic Advisory Board Meeting, Cambridge, MA, November 14-15, 2016. 2016 Invited Faculty, Aubagio Academy of Knowledge, “Optimizing Treatment Outcomes and AUBAGIO: Consistent Efficacy Across NNT Analyses, Extension, and Real-World Trials,” Amsterdam, Netherlands, November 4-5, 2016. 2016 Chair, Biogen’s National Leadership Council Meeting, Cambridge, MA, October 22, 2016. 2016 Clinical Expert, Ocrelizumab Safety Communications and MS Treatment Landscape Advisory Board Meeting, Dallas, TX, October 7, 2016. 2016 Chair, Catamount Medical Education, “ForuMS: Association of Vitamin D Levels with Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b,” August 10, 2016. 2016 Activity Chair, Catamount Medical Education, “ForuMS: Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis,” August 17, 2016. 2016 Invited Reviewer, NIH ETTN-M11 Review Meeting, Chicago, IL, June 23- 24, 2016. 2016 Chair, Vindico Symposium, “In Search of the Guiding Light: Re-visiting the Use of Oral and High-Efficacy